Where Innovations Meets Personalized and Precision Medicine
Editorial Staff
Editor-in-Chief

Prof. Massoud Houshmand

Medical Molecular Genetic
Professor in Genetic Diagnostic Department; NIGEB. Department of Medical Biotechnology, National Institute of Genetic Engineering and Biotechnology, Tehran, Iran.

massoudh@nigeb.ac.ir
0000-0002-2198-223X

Director-in-Charge

Dr. Mohammad Ali Saremi

Personalized Medicine Research Center of AmitisGen, Tehran, Iran.

masaremi@amitisgen.com

Editor’s Note

This issue of our journal brings together a diverse and thought-provoking collection of articles that reflect the dynamic evolution of biomedical science, clinical innovation, and environmental health. Each contribution provides a different viewpoint regarding the challenges and opportunities shaping modern healthcare and scientific research.

We start with an interesting study that looks at how the water-alcohol extract of purslane (Portulaca oleracea) can help with depression in mice that have asthma. By integrating traditional herbal medicine with behavioral neuroscience, this study contributes to the development of alternative therapies targeting inflammation-related mood disorders.

The second article explores the transformative role of artificial intelligence in anesthesia and anesthetic technology. From predictive algorithms to real-time monitoring systems, AI is rapidly redefining perioperative care by enhancing precision, safety, and decision-making capabilities.

Our third article addresses one of the most urgent threats in contemporary medicine: the rise of multidrug-resistant Acinetobacter species. This comprehensive review underscores the clinical challenges posed by these resilient pathogens and emphasizes the critical need for new antimicrobial strategies and stewardship practices.

The fourth article looks at how microplastics can harm brain health, which is becoming a serious issue that could affect how our brains work and lead to diseases that damage the nervous system. It offers a compelling overview of the biological pathways, mechanisms, and long-term risks associated with microplastic exposure.

We then turn to the field of pharmacogenomics, where genetic insights are revolutionizing drug development and personalizing treatment strategies. This article highlights how integrating genomic data into clinical practice can optimize therapeutic efficacy, minimize adverse effects, and pave the way for truly individualized medicine.

Concluding the issue is a comprehensive review of advancements in hysterectomy techniques for the treatment of women’s cancers. It evaluates emerging surgical innovations, clinical outcomes, and the evolving role of minimally invasive procedures in improving patient care and recovery. Together, these articles illuminate the frontiers of science and medicine, offering a rich blend of experimental insight, clinical relevance, and future potential. We hope this issue not only informs but also inspires our readers to engage deeply with the pressing scientific questions of our time.

Director-in-Charge of Personalized Medicine

Executive Manager

Nayyere Moslehi

MSc. MBA Ferdowsi University, Mashhad, Iran.

info@pmjournal.ir

Executive Team

Abbas Ardalan

ArmitaGen Genetics Laboratory, Tehran, Iran Molecular Genetics. .

ardalan@amitisgen.com

Executive Team

Dr. Roya Amirinejad

Molecular Genetics
PhD in Molecular Genetics, Tarbiat Modares University, Tehran, Iran.

roya.amirinejad@modares.ac.ir

Unfortunately, the Personal Medicine Journal has lost its valuable colleague. Words cannot describe how sorry we are for this loss. we will cherish his memory forever.